155 related articles for article (PubMed ID: 36297384)
41. Identification of lead BAY60-7550 analogues as potential inhibitors that utilize the hydrophobic groove in PDE2A: a molecular dynamics simulation study.
Kumar J; Umar T; Kausar T; Mobashir M; Nayeem SM; Hoda N
J Mol Model; 2017 Jan; 23(1):7. PubMed ID: 27966018
[TBL] [Abstract][Full Text] [Related]
42. Critical role of phosphodiesterase 2A in mouse congenital heart defects.
Assenza MR; Barbagallo F; Barrios F; Cornacchione M; Campolo F; Vivarelli E; Gianfrilli D; Auletta L; Soricelli A; Isidori AM; Lenzi A; Pellegrini M; Naro F
Cardiovasc Res; 2018 May; 114(6):830-845. PubMed ID: 29409032
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of 18F-CPFPX, a novel adenosine A1 receptor ligand: in vitro autoradiography and high-resolution small animal PET.
Bauer A; Holschbach MH; Cremer M; Weber S; Boy C; Shah NJ; Olsson RA; Halling H; Coenen HH; Zilles K
J Nucl Med; 2003 Oct; 44(10):1682-9. PubMed ID: 14530487
[TBL] [Abstract][Full Text] [Related]
44. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus.
Fernández-Fernández D; Rosenbrock H; Kroker KS
Synapse; 2015 Oct; 69(10):484-96. PubMed ID: 26178667
[TBL] [Abstract][Full Text] [Related]
46. Quantification of SV2A Binding in Rodent Brain Using [
Sadasivam P; Fang XT; Toyonaga T; Lee S; Xu Y; Zheng MQ; Spurrier J; Huang Y; Strittmatter SM; Carson RE; Cai Z
Mol Imaging Biol; 2021 Jun; 23(3):372-381. PubMed ID: 33258040
[TBL] [Abstract][Full Text] [Related]
47. Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates.
Stepanov V; Takano A; Nakao R; Amini N; Miura S; Hasui T; Kimura H; Taniguchi T; Halldin C
Nucl Med Biol; 2018 Feb; 57():12-19. PubMed ID: 29223715
[TBL] [Abstract][Full Text] [Related]
48. Effect of phosphodiesterase (1B, 2A, 9A and 10A) inhibitors on central nervous system cyclic nucleotide levels in rats and mice.
Chen J; Zook D; Crickard L; Tabatabaei A
Neurochem Int; 2019 Oct; 129():104471. PubMed ID: 31121256
[TBL] [Abstract][Full Text] [Related]
49. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L
J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236
[TBL] [Abstract][Full Text] [Related]
50. Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system.
Iffland A; Kohls D; Low S; Luan J; Zhang Y; Kothe M; Cao Q; Kamath AV; Ding YH; Ellenberger T
Biochemistry; 2005 Jun; 44(23):8312-25. PubMed ID: 15938621
[TBL] [Abstract][Full Text] [Related]
51. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
[TBL] [Abstract][Full Text] [Related]
52. Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor.
Helal CJ; Arnold EP; Boyden TL; Chang C; Chappie TA; Fennell KF; Forman MD; Hajos M; Harms JF; Hoffman WE; Humphrey JM; Kang Z; Kleiman RJ; Kormos BL; Lee CW; Lu J; Maklad N; McDowell L; Mente S; O'Connor RE; Pandit J; Piotrowski M; Schmidt AW; Schmidt CJ; Ueno H; Verhoest PR; Yang EX
J Med Chem; 2017 Jul; 60(13):5673-5698. PubMed ID: 28574706
[TBL] [Abstract][Full Text] [Related]
53. Species differences in mGluR5 binding sites in mammalian central nervous system determined using in vitro binding with [18F]F-PEB.
Patel S; Hamill TG; Connolly B; Jagoda E; Li W; Gibson RE
Nucl Med Biol; 2007 Nov; 34(8):1009-17. PubMed ID: 17998106
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
Shalgunov V; van Wieringen JP; Janssen HM; Fransen PM; Dierckx RA; Michel MC; Booij J; Elsinga PH
J Nucl Med; 2015 Jan; 56(1):133-9. PubMed ID: 25476538
[TBL] [Abstract][Full Text] [Related]
55. Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice.
Chen L; Cui S; Yu H; Li G; Liu N; Wu Q; Zhang HT; O'Donnell JM; Wang G; Xu Y
J Psychopharmacol; 2019 May; 33(5):568-576. PubMed ID: 30835157
[TBL] [Abstract][Full Text] [Related]
56. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
[TBL] [Abstract][Full Text] [Related]
57. Impact of structural alterations on the radiopharmacological profile of
Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
[TBL] [Abstract][Full Text] [Related]
58. PDE2A Is Indispensable for Mouse Liver Development and Hematopoiesis.
Barbagallo F; Rotilio V; Assenza MR; Aguanno S; Orsini T; Putti S; Isidori AM; Lenzi A; Naro F; De Angelis L; Pellegrini M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326334
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of [11C]PipISB and [18F]PipISB in monkey as candidate radioligands for imaging brain cannabinoid type-1 receptors in vivo.
Finnema SJ; Donohue SR; Zoghbi SS; Brown AK; Gulyás B; Innis RB; Halldin C; Pike VW
Synapse; 2009 Jan; 63(1):22-30. PubMed ID: 18925657
[TBL] [Abstract][Full Text] [Related]
60. Phosphodiesterase 2A is a major negative regulator of iNOS expression in lipopolysaccharide-treated mouse alveolar macrophages.
Rentsendorj O; D'Alessio FR; Pearse DB
J Leukoc Biol; 2014 Nov; 96(5):907-15. PubMed ID: 25063878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
